search
Back to results

Glucosamine Sulphate and Increased Level of Blood Cholesterol

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Glucosamine sulphate
Sponsored by
Slidgigtinstituttet
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring glucosamine sulphate, osteoarthritis, cholesterol,

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels - Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers -

Sites / Locations

  • Slidgigtinstituttet

Outcomes

Primary Outcome Measures

Levels of blood cholesterol

Secondary Outcome Measures

Effect of treatment on pain

Full Information

First Posted
November 7, 2005
Last Updated
November 7, 2005
Sponsor
Slidgigtinstituttet
Collaborators
Pharma Nord
search

1. Study Identification

Unique Protocol Identification Number
NCT00251069
Brief Title
Glucosamine Sulphate and Increased Level of Blood Cholesterol
Official Title
Glucosamine Sulphate and Hypercholesterolaemia
Study Type
Interventional

2. Study Status

Record Verification Date
July 2005
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Slidgigtinstituttet
Collaborators
Pharma Nord

4. Oversight

5. Study Description

Brief Summary
Glucosamine sulphate causes no changes in blood levels of cholesterol
Detailed Description
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
glucosamine sulphate, osteoarthritis, cholesterol,

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
66 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Glucosamine sulphate
Primary Outcome Measure Information:
Title
Levels of blood cholesterol
Secondary Outcome Measure Information:
Title
Effect of treatment on pain

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels - Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Keld Ostergaard, M.D., Ph.D.
Organizational Affiliation
Slidgigtinstituttet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Slidgigtinstituttet
City
Ishøj
ZIP/Postal Code
DK-2635
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Glucosamine Sulphate and Increased Level of Blood Cholesterol

We'll reach out to this number within 24 hrs